People: Anixa Biosciences Inc (ANIX.OQ)

ANIX.OQ on NASDAQ Stock Exchange Capital Market

30 Nov 2020
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Schlumpberger, Thomas 

Dr. Thomas Schlumpberger Ph.D. serves as Executive Vice President of the Company. Dr. Schlumpberger is an experienced executive with more than 20 years of experience working in the life sciences industry. As a business development executive, Dr. Schlumpberger has closed over 30 collaboration, distribution, and licensing deals totaling more than $1.5 billion in value. Prior to joining Anixa, Thomas held senior executive roles with several diagnostic companies, including InVitae, Affymetrix (now Thermo-Fisher Scientific), Inivata and Singulex. He earned degrees in electrical engineering and computer science from Engineering Academy Ravensburg and Technical University Munich before receiving his Ph.D. in molecular and cell biology from the University of California, Berkeley .

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --